Vitamin D is not really a vitamin. It is a steroid hormone precursor that your body synthesizes from cholesterol when skin is exposed to UVB radiation — and the global failure to get enough of it is one of the most consequential, most preventable health problems of the modern era. More than one billion people worldwide are estimated to be deficient or insufficient. Yet the official recommended dietary allowance in the United States remains a conservative 600 IU per day — a figure that most vitamin D researchers consider dangerously inadequate for the majority of adults.
This guide covers what the science actually says: why the RDA was set too low, what optimal blood levels look like, how to test, how to dose, and why you should almost never take vitamin D3 without K2.
The Institute of Medicine (now the National Academy of Medicine) set the current RDA of 600 IU in its landmark 2010 report. The goal was modest: ensure that 97.5% of the population reaches a 25(OH)D blood level of at least 20 ng/mL, which was deemed sufficient to prevent rickets and maintain bone health.
The problem is that 20 ng/mL as a threshold was calibrated to prevent bone disease — not to support the full spectrum of functions that vitamin D is now understood to perform. Dr. Michael Holick of Boston University, one of the world's leading vitamin D researchers and the scientist who first synthesized the active form of vitamin D, has argued for decades that the IOM's threshold is far too conservative. In a widely cited paper in the New England Journal of Medicine, Holick and colleagues outlined evidence that optimal health outcomes — immune function, cancer prevention, cardiovascular protection, neuromuscular performance — are associated with 25(OH)D levels of 40–60 ng/mL, not the 20 ng/mL threshold endorsed by the IOM.
The IOM report itself contained an acknowledged statistical error. Researchers Veith and Heaney noted that the IOM committee's own data, when re-analyzed, actually suggested 600 IU would only reliably get people to roughly 16 ng/mL — below their own minimum threshold. The error has been acknowledged but the RDA has not been formally revised.
The practical upshot: for most adults living at northern latitudes, working indoors, or with darker skin tones, 600 IU/day will not come close to sustaining 25(OH)D levels that research associates with optimal health.
Classifying vitamin D as a "vitamin" in the traditional sense is a misnomer. Once synthesized in the skin or absorbed from food, it undergoes two hydroxylation steps — first in the liver (to 25(OH)D, the storage form measured in blood tests), then in the kidneys and peripheral tissues (to 1,25(OH)₂D, calcitriol, the active hormonal form). Calcitriol binds to the vitamin D receptor (VDR), a nuclear receptor present in virtually every tissue in the body.
When calcitriol binds VDR, it functions like a master transcription regulator. Studies estimate that vitamin D directly or indirectly influences the expression of more than 2,000 genes — roughly 10% of the human genome. These include genes governing:
This breadth of genomic influence explains why vitamin D deficiency is associated with such a wide and seemingly unrelated constellation of health problems.
The most classical consequence of severe deficiency is rickets in children and osteomalacia in adults — conditions where bone mineral density fails due to inadequate calcium absorption. Even at subclinical deficiency levels, studies consistently show that low 25(OH)D is associated with significantly elevated fracture risk and accelerated osteoporotic progression. Muscle weakness is another under-recognized symptom: VDR is expressed throughout skeletal muscle, and proximal muscle weakness — particularly noticeable when climbing stairs or rising from a chair — is a frequent clinical sign of deficiency.
VDR is expressed on T cells, B cells, macrophages, and dendritic cells. Vitamin D upregulates the production of cathelicidin, a broad-spectrum antimicrobial peptide that helps neutralize bacteria, viruses, and fungi before the adaptive immune system is even engaged. Meta-analyses of randomized controlled trials have found that vitamin D supplementation reduces the risk of acute respiratory infections by approximately 12% overall, and by 50–70% in those with baseline deficiency. There is also a substantial body of epidemiological evidence linking low vitamin D to increased risk of autoimmune conditions including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, and inflammatory bowel disease.
Vitamin D influences tryptophan hydroxylase 2, the rate-limiting enzyme in brain serotonin synthesis. Low vitamin D is consistently associated with higher rates of depression and is a proposed contributor to Seasonal Affective Disorder (SAD), which peaks in winter when UVB exposure is minimal. While vitamin D supplementation is not a standalone treatment for clinical depression, several double-blind RCTs have documented mood improvements with correction of deficiency.
VDR is expressed in cardiomyocytes and vascular smooth muscle. Vitamin D inhibits renin synthesis — a key upstream regulator of blood pressure — and suppresses vascular smooth muscle cell proliferation. Epidemiological studies show strong inverse associations between 25(OH)D levels and hypertension, atherosclerosis, and cardiac events, though large RCTs (VITAL, D-HEALTH) have yielded mixed results, likely because many enrolled participants were not meaningfully deficient at baseline.
Vitamin D promotes differentiation of rapidly dividing cells and induces apoptosis in malignant cell lines. Ecological data show striking inverse correlations between solar UVB exposure and incidence of colorectal, breast, and prostate cancers. The VITAL trial — 25,871 participants over 5 years — found that 2,000 IU/day of D3 was associated with a 17% reduction in cancer mortality (statistically significant), though it did not reduce overall cancer incidence, suggesting vitamin D may primarily influence cancer progression and survival rather than initiation.
The only meaningful way to assess vitamin D status is a blood test measuring 25-hydroxyvitamin D [25(OH)D], also called calcidiol. This is the stable storage form with a half-life of roughly 2–3 weeks, making it the most reliable marker of overall vitamin D status. Do not confuse it with 1,25(OH)₂D (calcitriol), which is the active hormonal form — calcitriol is tightly regulated and often normal or even elevated in deficiency states.
| 25(OH)D Level | Classification | Clinical Picture |
|---|---|---|
| < 10 ng/mL | Severe deficiency | Rickets, osteomalacia, profound immune impairment |
| 10–19 ng/mL | Deficiency | Elevated fracture risk, muscle weakness, increased infection susceptibility |
| 20–29 ng/mL | Insufficiency | Meets IOM minimum; likely sub-optimal for non-skeletal functions |
| 30–39 ng/mL | Adequate (conservative) | Adequate by most guidelines; some researchers consider this borderline |
| 40–60 ng/mL | Optimal (functional medicine / Holick) | Associated with best outcomes for immune, cardiovascular, and cancer endpoints |
| 60–100 ng/mL | High-normal | Achievable only with supplementation; generally considered safe |
| > 150 ng/mL | Toxicity threshold | Hypercalcemia risk; almost exclusively from supplementation errors |
Testing is straightforward and inexpensive. Your doctor can order it as part of routine bloodwork. Alternatively, at-home finger-prick tests that you mail to a certified lab are now widely available and convenient.
→ At-Home Vitamin D Test Kit on AmazonThere are two supplemental forms of vitamin D: D3 (cholecalciferol), derived from lanolin (sheep's wool) or lichen (vegan sources), and D2 (ergocalciferol), derived from UV-irradiated yeast or fungi. For decades, D2 was the standard prescription form in the United States, and many clinicians still prescribe it.
A landmark head-to-head comparison published in the American Journal of Clinical Nutrition found that D3 raises and maintains 25(OH)D blood levels approximately 87% more effectively than an equivalent dose of D2. Subsequent meta-analyses have confirmed this finding. D3 has a longer half-life in circulation and is more efficiently converted to the active hormonal form. The mechanistic reason: D2 has a different side-chain structure that makes it less efficiently bound by the transport proteins that carry vitamin D to the liver for hydroxylation.
The practical recommendation is unambiguous: always choose D3 (cholecalciferol) over D2 (ergocalciferol). Vegans should look for D3 derived from lichen (Vitashine, for example), which is biologically identical to animal-derived D3 but sourced from algae/lichen.
This is arguably the most overlooked aspect of vitamin D supplementation. Vitamin D3 significantly increases intestinal calcium absorption — which is exactly the intended effect for bone health. The problem is that absorbed calcium needs to be directed into bones and teeth, not deposited in soft tissue, arteries, and kidneys. This traffic-control function belongs to vitamin K2.
Vitamin K2 activates two critical calcium-regulating proteins through a process called carboxylation:
Without adequate K2, uncarboxylated MGP cannot prevent arterial calcification even if calcium absorption is high. This is the mechanism researchers believe explains the cardiovascular findings in the Rotterdam Study, a large Dutch prospective cohort of nearly 5,000 adults: those with the highest dietary K2 intake had a 57% lower risk of dying from aortic calcification-related cardiovascular disease than those with the lowest intake. K1 (phylloquinone, the form in leafy greens) did not show the same protective effect — because K2 MK-7 has a much longer half-life in plasma and preferentially accumulates in extrahepatic tissues like the artery wall and bone.
Geleijnse et al. (2004) followed 4,807 Dutch participants for 10 years. High dietary vitamin K2 (menaquinone) intake was associated with a 41% reduction in coronary heart disease risk, 57% reduction in aortic calcification mortality, and 26% reduction in all-cause mortality. Vitamin K1 intake showed no significant associations.
The recommended form is MK-7 (menaquinone-7), the long-chain form found in fermented foods like natto. MK-7 has a plasma half-life of 72 hours versus MK-4's 1–2 hours, making it far more effective at sustained K2 activity in extrahepatic tissues. Typical doses used in research range from 90–360 mcg MK-7 per day.
The practical takeaway: if you supplement D3, take K2 MK-7 with it. A combined D3+K2 capsule is the most convenient option and the format most clinical practitioners now recommend.
→ Shop D3 + K2 MK-7 Supplements on AmazonVitamin D metabolism is enzyme-dependent at every step — and those enzymes require cofactors. The most critical is magnesium. A 2018 review by Uwitonze and Razzaque in the Journal of the American Osteopathic Association documented that all enzymes metabolizing vitamin D (vitamin D–25-hydroxylase, 25-hydroxyvitamin D–1α-hydroxylase, and 24-hydroxylase) are magnesium-dependent. Without adequate magnesium, supplemented vitamin D cannot be properly converted to its active form — meaning you can take substantial amounts of D3 and see little improvement in physiological effect if you are also magnesium deficient.
Magnesium deficiency is itself extremely common: surveys suggest roughly 45–68% of Americans do not meet the Estimated Average Requirement through diet. The best-absorbed forms for supplementation are magnesium glycinate and magnesium malate (magnesium oxide, the cheapest form, has poor bioavailability at roughly 4%).
Additional cofactors with supporting evidence include:
The ideal approach is to test first (25(OH)D baseline), supplement to target, then retest at 3 months. A rough rule of thumb from pharmacokinetic studies: in a typical adult, every 1,000 IU/day of D3 raises 25(OH)D by approximately 8–10 ng/mL, though individual variation is substantial due to body weight, gut absorption, baseline levels, and genetics (VDR polymorphisms).
| Population | Typical Maintenance Dose | Notes |
|---|---|---|
| Average fair-skinned adult (summer, equatorial) | 1,000–2,000 IU/day | Sun exposure may cover most needs in summer |
| Average adult, latitude >35°N, winter | 2,000–4,000 IU/day | No meaningful UVB available Oct–Mar above 35°N |
| Obese adults | 4,000–6,000 IU/day | Fat-soluble vitamin sequestered in adipose tissue |
| Dark-skinned adults at northern latitude | 3,000–5,000 IU/day | Higher melanin dramatically reduces skin synthesis |
| Adults over 65 | 2,000–4,000 IU/day | Skin synthesis efficiency declines ~75% with age |
For patients with confirmed deficiency (<20 ng/mL), many physicians use a structured loading protocol to replete stores rapidly before transitioning to maintenance dosing:
Note: The 50,000 IU loading dose requires physician supervision. It is not something to self-prescribe. Most practitioners use prescription-strength D2 (ergocalciferol) capsules for this protocol, though D3 at equivalent doses is increasingly preferred.
Human skin evolved to synthesize vitamin D from UVB radiation (wavelengths 290–315 nm). When UVB strikes 7-dehydrocholesterol in the skin, it is photochemically converted to pre-vitamin D3, which thermally isomerizes over 24–48 hours to vitamin D3. The exposure required to generate meaningful amounts depends on many factors, but a useful rough estimate: 10–20 minutes of midday sun exposure (10am–2pm) in summer, with arms and legs exposed, at latitudes below 35°N, generates approximately 10,000–20,000 IU of pre-vitamin D3 in fair-skinned individuals.
Several factors dramatically reduce this synthesis:
The public health advice to avoid all sun exposure and use sunscreen whenever outdoors — while sensible for skin cancer prevention — has contributed meaningfully to the global epidemic of vitamin D deficiency. Brief, intentional, unprotected midday sun exposure (without burning) is physiologically beneficial, and supplementation is strongly warranted when sun exposure is limited.
Do not supplement above 10,000 IU/day without physician supervision and regular blood testing. While vitamin D toxicity is rare, it is real and potentially serious. Hypercalcemia from vitamin D excess causes symptoms including nausea, weakness, frequent urination, kidney stones, and in severe cases, cardiac arrhythmia and kidney failure.
Toxicity in published case reports has almost exclusively occurred at sustained doses above 40,000–60,000 IU/day for weeks to months, or from manufacturing errors producing doses orders of magnitude higher than labeled. At doses of 4,000–10,000 IU/day, toxicity in otherwise healthy adults is extremely unlikely — but regular testing (every 3–6 months while adjusting dose) is still strongly recommended. The Endocrine Society's tolerable upper intake level is 10,000 IU/day for adults.
Notably, vitamin D from sun exposure does not cause toxicity — the skin has a feedback mechanism that degrades excess pre-vitamin D3 before it enters circulation. Toxicity is exclusively a risk of excessive supplementation.
Based on bioavailability data, combined D3+K2 formulations represent the most convenient and clinically rational approach for most adults. Look for products that specify MK-7 (not MK-4) as the K2 source and list at least 90–200 mcg of K2 per serving. An at-home test kit makes it easy to track progress without a doctor's visit.
→ D3 + K2 MK-7 Supplement on Amazon → At-Home Vitamin D Test Kit on AmazonVitamin D is a steroid hormone that regulates over 2,000 genes, sits at the intersection of immune defense, bone metabolism, cardiovascular health, mood regulation, and cancer biology — and more than a billion people are not getting enough of it. The 600 IU RDA was designed to prevent rickets, not optimize health. For most adults, especially those at northern latitudes, working indoors, or with darker skin, daily supplementation of 2,000–4,000 IU of D3, paired with K2 MK-7 and magnesium, is a low-risk, high-upside intervention. Test your levels, dose to target, and retest. The 20 ng/mL "sufficient" threshold is the floor — not the ceiling.
As an Amazon Associate, LongevityLab earns from qualifying purchases made through links on this page. This does not affect the price you pay.